Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
Target-Kategorie:
BUD13
Application Verdünnung:
WB: 1:1000, IHC-P: 1:50-100, FACS: 1:10-50
BUD13 Antibody (C-term) western blot analysis in HepG2 cell line lysates (35 ug/lane). This demonstrates the BUD13 antibody detected the BUD13 protein (arrow).
BUD13 Antibody (C-term) western blot analysis in mouse kidney tissue lysates (35 ug/lane). This demonstrates the BUD13 antibody detected the BUD13 protein (arrow).
BUD13 antibody (C-term) immunohistochemistry analysis in formalin fixed and paraffin embedded human hepatocarcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the BUD13 antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated.
BUD13 Antibody (C-term) flow cytometric analysis of HepG2 cells (right histogram) compared to a negative control cell (left histogram). FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.
orb28690
Western blot analysis of mouse kidney tissue lysates (35ug/lane) using BUD13 antibody (C-term)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
